Home » Electronics & Semiconductors » Medigene AG: Medigene announces participation at upcoming investor and scientific conferences

Medigene AG: Medigene announces participation at upcoming investor and scientific conferences




Medigene AG (FSE: MDG1, Prime Standard, TecDAX) today announced its participation at four upcoming investor and scientific conferences:

American Society of Hematology (ASH) Annual Meeting

Date: 9 – 12 December 2017

Location: Atlanta, USA

Guggenheim–s 5th Annual Boston Healthcare Conference

Date: 13 December 2017

Location: Boston, USA

JP Morgan Healthcare Conference

Trout Access

Date: 8 – 11 January 2018

Location: San Francisco, USA

ODDO BHF Forum 2018

Date: 11 – 12 January 2018

Location: Lyon, France

This press release contains forward-looking statements representing the opinion of Medigene as of the date of this release. The actual results achieved by Medigene may differ significantly from the forward-looking statements made herein. Medigene is not bound to update any of these forward-looking statements. Medigene® is a registered trademark of Medigene AG. This trademark may be owned or licensed in select locations only.

Medigene AG (FSE: MDG1, ISIN DE000A1X3W00, Prime Standard, TecDAX) is a publicly listed biotechnology company headquartered in Martinsried near Munich, Germany. The company is developing highly innovative immunotherapies to target various forms and stages of cancer. Medigene concentrates on the development of personalized T cell-based therapies, with associated projects currently in pre-clinical and clinical development.

For more information, please visit www.medigene.com





Posted by on 4. December 2017. Filed under Electronics & Semiconductors. You can follow any responses to this entry through the RSS 2.0. You can leave a response or trackback to this entry

Leave a Reply

Archive

© 2017 So-Co-IT. All Rights Reserved. Log in - Copyright by LayerMedia


Blogverzeichnis - Blog Verzeichnis bloggerei.de Blog Top Liste - by TopBlogs.de Bloggeramt.de